ARGX vs REGN: Which Stock is Better?

Side-by-side comparison of Argenx Se and Regeneron Pharmaceuticals Inc in 2026

Comparison Updated:

ARGX

Argenx Se

$684.77

REGN

Regeneron Pharmaceuticals Inc

$744.12

Key Metrics Comparison

MetricARGXREGNWinner
Market Cap$43.69B$80.25BREGN
P/E Ratio36.1018.32REGN
EPS (TTM)$19.56$41.44REGN
Revenue Growth0.7%0.0%ARGX
Gross Margin57.3%44.6%ARGX

Analyze ARGX

Full quant analysis

Analyze REGN

Full quant analysis

Analyze Each Stock

Frequently Asked Questions

Is ARGX or REGN a better investment?

Comparing ARGX and REGN: Argenx Se has a market cap of $43.69B while Regeneron Pharmaceuticals Inc has $80.25B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.

What is the difference between ARGX and REGN?

ARGX (Argenx Se) and REGN (Regeneron Pharmaceuticals Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.

Which stock has better value: ARGX or REGN?

Based on P/E ratios, REGN trades at a lower multiple (18.3x vs 36.1x).

Which is growing faster: ARGX or REGN?

ARGX has higher revenue growth at 0.7% vs 0.0% for REGN.

Which company is more profitable: ARGX or REGN?

Argenx Se (ARGX) has higher gross margins at 57.3% compared to 44.6% for REGN.

Which is the larger company: ARGX or REGN?

Regeneron Pharmaceuticals Inc (REGN) is larger with a market cap of $80.25B compared to $43.69B for ARGX.

Should I buy ARGX or REGN in 2026?

Both ARGX and REGN have investment merit. ARGX trades at $684.77 while REGN trades at $744.12. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.

What are the key differences between ARGX and REGN stock?

Key differences: Market Cap ($43.69B vs $80.25B), P/E Ratio (36.1x vs 18.3x), Revenue Growth (0.7% vs 0.0%), Gross Margin (57.3% vs 44.6%).

Popular Stock Comparisons